| RS2101633023 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2101635447 |
DNAJC6
|
Health Risk |
Pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile onset Parkinson disease 19A |
| RS2101637757 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS2101641171 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Symmetrical dyschromatosis of extremities |
| RS2101641985 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101642015 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS2101642546 |
SF3B4
|
Health Risk |
Likely pathogenic |
— |
| RS2101644365 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Symmetrical dyschromatosis of extremities |
| RS2101645916 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS2101646017 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Nager syndrome |
| RS2101646027 |
FLG
|
Health Risk |
Likely pathogenic |
Ichthyosis vulgaris, Ichthyosis vulgaris |
| RS2101647629 |
BSND
|
Health Risk |
Pathogenic |
— |
| RS2101647663 |
SF3B4
|
Health Risk |
Pathogenic |
— |
| RS2101647799 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Nager syndrome |
| RS2101648820 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Nager syndrome |
| RS2101651357 |
CCDST;FLG
|
Health Risk |
Likely pathogenic |
Ichthyosis vulgaris, Ichthyosis vulgaris |
| RS2101652956 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2101653580 |
COL11A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2101653586 |
ADAMTSL4
|
Health Risk |
Likely pathogenic |
— |
| RS2101656625 |
RORC
|
Health Risk |
Likely pathogenic |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency |
| RS2101672500 |
CASQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2101678386 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2101678623 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS2101678782 |
COL11A1
|
Health Risk |
Likely pathogenic |
Autism, Neurodevelopmental delay |
| RS2101683875 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2101688490 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2101701634 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS2101705947 |
ATF6
|
Health Risk |
Likely pathogenic |
— |
| RS2101713372 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS2101730664 |
HFM1
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2101738598 |
NRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 6, Noonan syndrome 6 |
| RS2101741276 |
SPTA1
|
Health Risk |
Likely pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS2101742052 |
NRAS
|
Health Risk |
Pathogenic |
RASopathy, Colorectal cancer |
| RS2101743991 |
NRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 6, Noonan syndrome 6 |
| RS2101744255 |
NRAS
|
Health Risk |
Likely pathogenic |
NRAS-related disorder, NRAS-related disorder |
| RS2101750154 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101760572 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101781113 |
SLC19A2
|
Health Risk |
Pathogenic |
— |
| RS2101782564 |
KCNN3
|
Health Risk |
Pathogenic |
Zimmermann-Laband syndrome 3, Zimmermann-Laband syndrome 3 |
| RS2101787377 |
SLC19A2
|
Health Risk |
Likely pathogenic |
— |
| RS2101794024 |
COL11A1
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal dominant 37 |
| RS2101800665 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal dominant 37 |
| RS2101804576 |
PEX19
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS2101804905 |
PEX19
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS2101810760 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2101818393 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2101818861 |
F5
|
Health Risk |
Likely pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2101819646 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101819850 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2101820716 |
GORAB
|
Health Risk |
Likely pathogenic |
— |
| RS2101821379 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2101821382 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS2101829195 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS2101829513 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101837157 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101839185 |
CFAP45
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS2101846610 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS2101847449 |
CFAP45
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS2101847465 |
COPA
|
Health Risk |
Likely pathogenic |
Autoimmune interstitial lung disease-arthritis syndrome, Autoimmune interstitial lung disease-arthritis syndrome |
| RS2101848342 |
CFAP45
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS2101851488 |
PPOX
|
Health Risk |
Likely pathogenic |
— |
| RS2101852537 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101857591 |
SPTA1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 3, Hereditary spherocytosis type 3 |
| RS2101862742 |
PPOX
|
Health Risk |
Pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS2101863458 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS2101868872 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101869722 |
COL11A1
|
Health Risk |
Pathogenic |
Stickler syndrome, Stickler syndrome |
| RS2101876357 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS2101876868 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, childhood-onset |
| RS2101877463 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 3, Hereditary spherocytosis type 3 |
| RS2101877791 |
RBM8A
|
Health Risk |
Pathogenic |
Radial aplasia-thrombocytopenia syndrome, Radial aplasia-thrombocytopenia syndrome |
| RS2101880713 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS2101880773 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS2101881414 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS2101882373 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS2101886022 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS2101886463 |
PPOX
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2101887841 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS2101889658 |
NCSTN
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS2101890460 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101890748 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101891457 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS2101892539 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101898546 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS2101899012 |
NCSTN
|
Health Risk |
Likely pathogenic |
— |
| RS2101899230 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101900643 |
SPTA1
|
Health Risk |
Likely pathogenic |
SPTA1-related disorder, SPTA1-related disorder |
| RS2101901339 |
PPOX
|
Health Risk |
Pathogenic |
— |
| RS2101902523 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, Variegate porphyria |
| RS2101904247 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2101906549 |
NCSTN
|
Health Risk |
Pathogenic |
— |
| RS2101908951 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS2101909450 |
NCSTN
|
Health Risk |
Pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS2101916656 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS2101919778 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101924403 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2101936731 |
GLUL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutamine synthetase stabilization disorder, Developmental and epileptic encephalopathy |
| RS2101942740 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 3, Hereditary spherocytosis type 3 |
| RS2101946013 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS2101946145 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |